Opioids
- Odds of Opioid Overdose Increased With Household Opioid Availability
- Amphastar Gets FDA Approval for Intranasal Naloxone Product
- Buprenorphine Out-of-Pocket Expenses Decreasing in the US
- Are Low-Dose Opioids Safe, Effective to Treat Refractory Restless Leg Syndrome?
- Two Perioperative Dexamethasone Doses May Reduce Opioid Use in Total Knee, Hip Arthroplasty
- Tapering Long-Term Opioid Treatment May Have Unintended Health Effects
- Trends Show Opioids Commonly Prescribed After Thyroid Procedures
- FDA Restricts Unlawful Import of Xylazine-Containing Products
- Opioid Rotation to Levorphanol in Patients With Cancer Is Associated With Improved Pain, Symptom Control
- FDA Committees Support OTC Availability of Narcan Nasal Spray
- Opioid Prescription Can Be Eliminated After Urologic Cancer Surgery
- Opioid Tapering May Have Unintended Negative Consequences
Conference Coverage
MORE MEETINGS
Clinical Tools
Powered by
Powered by 
